Investigation of safety and efficacy of intrathecal and intravenous injection of umbilical cord-derived mesenchymal stem cells - Trial IRCT20161212031362N3
Access comprehensive clinical trial information for IRCT20161212031362N3 through Pure Global AI's free database. This Phase 1 trial is sponsored by Tehran University of Medical Sciences and is currently Completed. The study focuses on Multiple sclerosis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
IRCT20161212031362N3
Phase 1
Completed
drug
Trial Details
Iranian Registry Of Clinical Trial • IRCT20161212031362N3
Investigation of safety and efficacy of intrathecal and intravenous injection of umbilical cord-derived mesenchymal stem cells
Investigation of safety and efficacy of intrathecal and intravenous injection of umbilical cord-derived mesenchymal stem cells (UC-MSC) in patients with multiple sclerosis
Study Focus
Sponsor & Location
Tehran University of Medical Sciences
Iran
Timeline & Enrollment
Phase 1
Jan 20, 2023
N/A
ICD-10 Classifications
Multiple sclerosis
Progressive systemic sclerosis
Systemic sclerosis
Systemic sclerosis, unspecified
Diffuse sclerosis
Data Source
Iranian Registry Of Clinical Trial
IRCT20161212031362N3
Non-Device Trial